| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology, Bayerische Julius-Maximilians-Universität Würzburg, Germany.
Address correspondence and reprint requests to Dr. Georg Becker, Department of Neurology, University of Würzburg, Josef-Schneider-Str. 11, Würzburg, Germany; e-mail: georg.becker{at}mail.uni-wuerzburg.de
BACKGROUND: Patients with Parkinson’s disease (PD) exhibit an increased echogenicity of the substantia nigra (SN) on transcranial sonography. Some healthy adults with the same echo characteristics showed a reduced 18fluorodopa uptake on PET, indicating a subclinical alteration of the nigrostriatal system.
OBJECTIVES: To determine whether the sonographic phenotype of hyperechogenic SN has any relevance for motor function in elderly subjects and whether an increased echogenicity of the SN is associated with an impaired motor function.
METHOD: In a population-based, cross-sectional study, 93 subjects older then 60 years without history of extrapyramidal disorder underwent sonographic and neurologic examinations, with a quantitative motor assessment.
RESULTS: Elderly healthy subjects without prediagnosed extrapyramidal disorder but with SN hyperechogenicity had more frequent and more severe parkinsonian symptoms and a slower finger tapping than those with a regular echogenicity of the SN (p < 0.05, U test).
CONCLUSION: With increasing age, subjects with SN hyperechogenicity develop a more substantial slowing of movements than subjects without this echo pattern, stressing the functional relevance of this sonographic finding. The authors speculate that hyperechogenicity of the SN may be detected by transcranial sonography early in life and may serve as a risk marker for nigral injury, although only a minority of these subjects will develop the full clinical picture of PD.
This article has been cited by other articles:
|
|
 |
|
  W. Poewe Treatments for Parkinson disease--past achievements and current clinical needs Neurology, February 17, 2009; 72(7_Supplement_2): S65 - S73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Morrens, W. Hulstijn, and B. Sabbe Psychomotor Slowing in Schizophrenia Schizophr Bull, July 1, 2007; 33(4): 1038 - 1053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Walter, J. Hoeppner, L. Prudente-Morrissey, S. Horowski, S. C. Herpertz, and R. Benecke Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders Brain, July 1, 2007; 130(7): 1799 - 1807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Poewe The need for neuroprotective therapies in Parkinson's disease: A clinical perspective Neurology, May 23, 2006; 66(10_suppl_4): S2 - S9. [Abstract] [Full Text]
|
|
|
|
|
|
A. W. Michell, S. J. G. Lewis, T. Foltynie, and R. A. Barker Biomarkers and Parkinson's disease Brain, August 1, 2004; 127(8): 1693 - 1705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V.L. Marshall, D.G. Grosset, U. Walter, R. Benecke, and D. Dressler Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes Neurology, September 23, 2003; 61(6): 871 - 871. [Full Text] [PDF]
|
|
|
|
|
|
U. Walter, L. Niehaus, T. Probst, R. Benecke, B. U. Meyer, and D. Dressler Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes Neurology, January 14, 2003; 60(1): 74 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Berg, W. Roggendorf, U. Schroder, R. Klein, T. Tatschner, P. Benz, O. Tucha, M. Preier, K. W. Lange, K. Reiners, et al. Echogenicity of the Substantia Nigra: Association With Increased Iron Content and Marker for Susceptibility to Nigrostriatal Injury Arch Neurol, June 1, 2002; 59(6): 999 - 1005. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
